Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-19-003593
Filing Date
2019-03-05
Accepted
2019-03-05 16:16:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b3030419_relmadatherap.htm 424B3 1673629
  Complete submission text file 0001213900-19-003593.txt   1674678
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-229258 | Film No.: 19658537
SIC: 2834 Pharmaceutical Preparations